Sandbox fungal meningitis

Jump to navigation Jump to search

Meningitis Main Page

Patient Information

Overview

Causes

Classification

Viral Meningitis
Bacterial Meningitis
Fungal Meningitis

Differential Diagnosis

Diagnosis

Treatment

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ;Sheng Shi, M.D. [2]


fungal meningitis

Blastomyces

Blastomyces
Preferred Regimen
Liposomal amphotericin B 5 mg/kg/day for 4–6 weeks
Followed By
Fluconazole 800 mg/day PO
OR
Itraconazole 200 mg PO bid or tid
OR
Voriconazole 200–400 mg IV q12h


Candidiasis

Candidiasis
Preferred Regimen
lipid-based ampho B 3–5 mg/kg/day
PLUS OR NOT
5-Fluorocytosine 25 mg/kg PO qid
Alternative Regimen
Fluconazole 400–800 mg (6–12 mg/kg) IV or PO


Histoplasma

Histoplasma
Preferred Regimen
Liposomal ampho B 5 mg/kg/d, for a total of 175 mg/kg over 4-6 wk
Followed By
Itraconazole 200 mg/day PO bid or tid for at least 12 month


Coccidioides

Coccidioides
Preferred Regimen
FLuconazole 400 mg/day PO
OR
Itraconazole 400–600 mg/day


===Cryptococcus HIV/AIDS===[1]

Cryptococcus, HIV/AIDS
Induction Phrase(for 2 wks)
Amphotericin B deoxycholate 0.7 mg/kg/day IV
PLUS
5-Fluorocytosine 100 mg/kg/day PO
Consolidation phase(for 8 wks)
Fluconazole 400 mg/day PO
OR
Itraconazole 400 mg/day
Maintenance phase
Fluconazole 200 mg/day


===Cryptococcus Immunocompetent===[2]

Cryptococcus, Immunocompetent
Induction Phrase(for 2 wks)
Amphotericin B 0.7-1 mg/kg/day IV
OR
Liposomal amphotericin B 5 mg/kg/day PO
PLUS
5-Fluorocytosine 25 mg/kg PO q6h
Consolidation phase(for 8 wks)
Fluconazole 400 mg/day PO
Maintenance phase(for 12 mo)
Fluconazole 200 mg/day



References

  1. Antinori S (2013) New Insights into HIV/AIDS-Associated Cryptococcosis. ISRN AIDS 2013 ():471363.http://dx.doi.org/10.1155/2013/471363 DOI:10.1155/2013/471363] PMID: 24052889
  2. Jackson A, van der Horst C (2012) New insights in the prevention, diagnosis, and treatment of cryptococcal meningitis. Curr HIV/AIDS Rep 9 (3):267-77. DOI:10.1007/s11904-012-0127-7 PMID: 22763808